{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:35:12Z","timestamp":1791506112279,"version":"4.3.4"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009017","name":"ALS Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2020-06376"],"award-info":[{"award-number":["RGPIN-2020-06376"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["DGECR-2020-00060"],"award-info":[{"award-number":["DGECR-2020-00060"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2018-06227"],"award-info":[{"award-number":["RGPIN-2018-06227"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["DGECR-2018-00093"],"award-info":[{"award-number":["DGECR-2018-00093"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["Junior 1"],"award-info":[{"award-number":["Junior 1"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are related neurodegenerative diseases that belong to a common disease spectrum based on overlapping clinical, pathological and genetic evidence. Early pathological changes to the morphology and synapses of affected neuron populations in ALS\/FTD suggest a common underlying mechanism of disease that requires further investigation. Fused in sarcoma (FUS) is a DNA\/RNA-binding protein with known genetic and pathological links to ALS\/FTD. Expression of ALS-linked FUS mutants in mice causes cognitive and motor defects, which correlate with loss of motor neuron dendritic branching and synapses, in addition to other pathological features of ALS\/FTD. The role of ALS-linked FUS mutants in causing ALS\/FTD-associated disease phenotypes is well established, but there are significant gaps in our understanding of the cell-autonomous role of FUS in promoting structural changes to motor neurons, and how these changes relate to disease progression. Here we generated a neuron-specific FUS-transgenic mouse model expressing the ALS-linked human FUSR521G variant, hFUS<jats:sup>R521G\/Syn1<\/jats:sup>, to investigate the cell-autonomous role of FUSR521G in causing loss of dendritic branching and synapses of motor neurons, and to understand how these changes relate to ALS-associated phenotypes. Longitudinal analysis of mice revealed that cognitive impairments in juvenile hFUS<jats:sup>R521G\/Syn1<\/jats:sup> mice coincide with reduced dendritic branching of cortical motor neurons in the absence of motor impairments or changes in the neuromorphology of spinal motor neurons. Motor impairments and dendritic attrition of spinal motor neurons developed later in aged hFUS<jats:sup>R521G\/Syn1<\/jats:sup> mice, along with FUS cytoplasmic mislocalisation, mitochondrial abnormalities and glial activation. Neuroinflammation promotes neuronal dysfunction and drives disease progression in ALS\/FTD. The therapeutic effects of inhibiting the pro-inflammatory nuclear factor kappa B (NF-\u03baB) pathway with an analog of Withaferin A, IMS-088, were assessed in symptomatic hFUS<jats:sup>R521G\/Syn1<\/jats:sup> mice and were found to improve cognitive and motor function, increase dendritic branches and synapses of motor neurons, and attenuate other ALS\/FTD-associated pathological features. Treatment of primary cortical neurons expressing FUSR521G with IMS-088 promoted the restoration of dendritic mitochondrial numbers and mitochondrial activity to wild-type levels, suggesting that inhibition of NF-\u03baB permits the restoration of mitochondrial stasis in our models. Collectively, this work demonstrates that FUSR521G has a cell-autonomous role in causing early pathological changes to dendritic and synaptic structures of motor neurons, and that these changes precede motor defects and other well-known pathological features of ALS\/FTD. Finally, these findings provide further support that modulation of the NF-\u03baB pathway in ALS\/FTD is an important therapeutic approach to attenuate disease.<\/jats:p>","DOI":"10.1186\/s40478-023-01671-1","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T09:02:43Z","timestamp":1700125363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-\u03baB inhibition"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-1951","authenticated-orcid":false,"given":"Mari Carmen","family":"Pelaez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2033-0664","authenticated-orcid":false,"given":"Antoine","family":"Desmeules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6389-8247","authenticated-orcid":false,"given":"Pauline A.","family":"Gelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5633-7266","authenticated-orcid":false,"given":"Bastien","family":"Glasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2746-3817","authenticated-orcid":false,"given":"Laetitia","family":"Marcadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Phaneuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1500-8158","authenticated-orcid":false,"given":"Silvia","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7965-8870","authenticated-orcid":false,"given":"Paul A.","family":"Dutchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Julien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9839-0611","authenticated-orcid":false,"given":"Chantelle F.","family":"Sephton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"issue":"7","key":"1671_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1212\/WNL.59.7.1077","volume":"59","author":"C Lomen-Hoerth","year":"2002","unstructured":"Lomen-Hoerth C, Anderson T, Miller B (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59(7):1077\u20131079","journal-title":"Neurology"},{"issue":"3\u20134","key":"1671_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong MJ et al (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18(3\u20134):153\u2013174","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1671_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fnins.2019.00951","volume":"13","author":"S Benbrika","year":"2019","unstructured":"Benbrika S et al (2019) Cognitive, emotional and psychological manifestations in amyotrophic lateral sclerosis at baseline and overtime: a review. Front Neurosci 13:951","journal-title":"Front Neurosci"},{"issue":"5","key":"1671_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-004-0900-9","volume":"108","author":"AM Lipton","year":"2004","unstructured":"Lipton AM, White CL 3rd, Bigio EH (2004) Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol 108(5):379\u2013385","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1671_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257\u2013268","journal-title":"Neuron"},{"issue":"2","key":"1671_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245\u2013256","journal-title":"Neuron"},{"issue":"5796","key":"1671_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u2013133","journal-title":"Science"},{"issue":"3","key":"1671_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602\u2013611","journal-title":"Biochem Biophys Res Commun"},{"issue":"5918","key":"1671_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323(5918):1208\u20131211","journal-title":"Science"},{"issue":"5918","key":"1671_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski Jr","year":"2009","unstructured":"Kwiatkowski TJ Jr et al (2009) Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323(5918):1205\u20131208","journal-title":"Science"},{"issue":"Pt 11","key":"1671_CR11","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/brain\/awp214","volume":"132","author":"M Neumann","year":"2009","unstructured":"Neumann M et al (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132(Pt 11):2922\u20132931","journal-title":"Brain"},{"key":"1671_CR12","doi-asserted-by":"publisher","first-page":"1000183","DOI":"10.3389\/fnmol.2022.1000183","volume":"15","author":"PA Gelon","year":"2022","unstructured":"Gelon PA, Dutchak PA, Sephton CF (2022) Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease. Front Mol Neurosci 15:1000183","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"1671_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/WNL.0b013e3181ccc732","volume":"74","author":"T Van Langenhove","year":"2010","unstructured":"Van Langenhove T et al (2010) Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 74(5):366\u2013371","journal-title":"Neurology"},{"issue":"5","key":"1671_CR14","doi-asserted-by":"publisher","first-page":"1016.e9","DOI":"10.1016\/j.neurobiolaging.2011.08.004","volume":"33","author":"ED Huey","year":"2012","unstructured":"Huey ED et al (2012) FUS and TDP43 genetic variability in FTD and CBS. Neurobiol Aging 33(5):1016.e9\u201317","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1671_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00401-009-0598-9","volume":"118","author":"DG Munoz","year":"2009","unstructured":"Munoz DG et al (2009) FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118(5):617\u2013627","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1671_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/NEN.0b013e318264f164","volume":"71","author":"N Suzuki","year":"2012","unstructured":"Suzuki N et al (2012) FUS\/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS\/TLS mutation. J Neuropathol Exp Neurol 71(9):779\u2013788","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"1671_CR17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/15476286.2016.1211225","volume":"13","author":"F Svetoni","year":"2016","unstructured":"Svetoni F, Frisone P, Paronetto MP (2016) Role of FET proteins in neurodegenerative disorders. RNA Biol 13(11):1089\u20131102","journal-title":"RNA Biol"},{"issue":"1","key":"1671_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40478-022-01314-x","volume":"10","author":"G Nicolas","year":"2022","unstructured":"Nicolas G et al (2022) A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics. Acta Neuropathol Commun 10(1):20","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"1671_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00415-009-5404-z","volume":"257","author":"H Seelaar","year":"2010","unstructured":"Seelaar H et al (2010) Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J Neurol 257(5):747\u2013753","journal-title":"J Neurol"},{"issue":"2","key":"1671_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/0014-4886(79)90129-8","volume":"63","author":"RP Hammer Jr","year":"1979","unstructured":"Hammer RP Jr, Tomiyasu U, Scheibel AB (1979) Degeneration of the human Betz cell due to amyotrophic lateral sclerosis. Exp Neurol 63(2):336\u201346","journal-title":"Exp Neurol"},{"issue":"3","key":"1671_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ana.410160306","volume":"16","author":"DS Horoupian","year":"1984","unstructured":"Horoupian DS et al (1984) Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies. Ann Neurol 16(3):305\u2013313","journal-title":"Ann Neurol"},{"key":"1671_CR22","doi-asserted-by":"publisher","first-page":"41765","DOI":"10.1038\/srep41765","volume":"7","author":"B Genc","year":"2017","unstructured":"Genc B et al (2017) Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS. Sci Rep 7:41765","journal-title":"Sci Rep"},{"issue":"10","key":"1671_CR23","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/jnnp.54.10.932","volume":"54","author":"I Ferrer","year":"1991","unstructured":"Ferrer I et al (1991) Dementia of frontal lobe type and motor neuron disease. A Golgi study of the frontal cortex. J Neurol Neurosurg Psychiatry 54(10):932\u20134","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1671_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF00686790","volume":"75","author":"T Kato","year":"1987","unstructured":"Kato T, Hirano A, Donnenfeld H (1987) A Golgi study of the large anterior horn cells of the lumbar cords in normal spinal cords and in amyotrophic lateral sclerosis. Acta Neuropathol 75(1):34\u201340","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1671_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00401-017-1797-4","volume":"135","author":"CM Henstridge","year":"2018","unstructured":"Henstridge CM et al (2018) Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis. Acta Neuropathol 135(2):213\u2013226","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1671_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00296180","volume":"87","author":"S Sasaki","year":"1994","unstructured":"Sasaki S, Maruyama S (1994) Decreased synaptophysin immunoreactivity of the anterior horns in motor neuron disease. Acta Neuropathol 87(2):125\u2013128","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1671_CR27","first-page":"128","volume":"7","author":"X Liu","year":"1996","unstructured":"Liu X, Erikson C, Brun A (1996) Cortical synaptic changes and gliosis in normal aging, Alzheimer\u2019s disease and frontal lobe degeneration. Dementia 7(3):128\u2013134","journal-title":"Dementia"},{"issue":"Suppl 1","key":"1671_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000051214","volume":"10","author":"I Ferrer","year":"1999","unstructured":"Ferrer I (1999) Neurons and their dendrites in frontotemporal dementia. Dement Geriatr Cogn Disord 10(Suppl 1):55\u201360","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"8","key":"1671_CR29","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/archneur.58.8.1233","volume":"58","author":"AM Lipton","year":"2001","unstructured":"Lipton AM et al (2001) Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. Arch Neurol 58(8):1233\u20131239","journal-title":"Arch Neurol"},{"issue":"2","key":"1671_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/neur.1995.0021","volume":"4","author":"A Brun","year":"1995","unstructured":"Brun A, Liu X, Erikson C (1995) Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer\u2019s disease and in frontal lobe degeneration. Neurodegeneration 4(2):171\u2013177","journal-title":"Neurodegeneration"},{"issue":"1","key":"1671_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s40478-022-01455-z","volume":"10","author":"ZI Laszlo","year":"2022","unstructured":"Laszlo ZI et al (2022) Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex. Acta Neuropathol Commun 10(1):156","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1671_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15252\/emmm.201708202","volume":"10","author":"ME Umoh","year":"2018","unstructured":"Umoh ME et al (2018) A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med 10(1):48\u201362","journal-title":"EMBO Mol Med"},{"issue":"1","key":"1671_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ijms20010004","volume":"20","author":"MO Iridoy","year":"2018","unstructured":"Iridoy MO et al (2018) Neuroanatomical quantitative proteomics reveals common pathogenic biological routes between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Int J Mol Sci 20(1):4","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1671_CR34","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1021\/pr2012279","volume":"11","author":"D Martins-de-Souza","year":"2012","unstructured":"Martins-de-Souza D et al (2012) Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration. J Proteome Res 11(4):2533\u20132543","journal-title":"J Proteome Res"},{"issue":"7","key":"1671_CR35","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/acn3.51407","volume":"8","author":"M Malpetti","year":"2021","unstructured":"Malpetti M et al (2021) Synaptic density in carriers of C9orf72 mutations: a [(11) C]UCB-J PET study. Ann Clin Transl Neurol 8(7):1515\u20131523","journal-title":"Ann Clin Transl Neurol"},{"issue":"14","key":"1671_CR36","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.neuron.2021.05.020","volume":"109","author":"D Lall","year":"2021","unstructured":"Lall D et al (2021) C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation. Neuron 109(14):2275\u20132291","journal-title":"Neuron"},{"issue":"1","key":"1671_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-019-0674-x","volume":"7","author":"LS Wu","year":"2019","unstructured":"Wu LS et al (2019) Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons. Acta Neuropathol Commun 7(1):50","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"1671_CR38","first-page":"3630","volume":"27","author":"EE Handley","year":"2017","unstructured":"Handley EE et al (2017) Synapse dysfunction of layer V pyramidal neurons precedes neurodegeneration in a mouse model of TDP-43 proteinopathies. Cereb Cortex 27(7):3630\u20133647","journal-title":"Cereb Cortex"},{"issue":"7","key":"1671_CR39","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/brainsci11070883","volume":"11","author":"MS Dyer","year":"2021","unstructured":"Dyer MS, Woodhouse A, Blizzard CA (2021) Cytoplasmic human TDP-43 mislocalization induces widespread dendritic spine loss in mouse upper motor neurons. Brain Sci 11(7):883","journal-title":"Brain Sci"},{"issue":"4","key":"1671_CR40","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/jnc.15214","volume":"157","author":"MS Dyer","year":"2021","unstructured":"Dyer MS et al (2021) Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex. J Neurochem 157(4):1300\u20131315","journal-title":"J Neurochem"},{"key":"1671_CR41","doi-asserted-by":"publisher","first-page":"37968","DOI":"10.1038\/srep37968","volume":"6","author":"MJ Fogarty","year":"2016","unstructured":"Fogarty MJ et al (2016) Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis. Sci Rep 6:37968","journal-title":"Sci Rep"},{"issue":"44","key":"1671_CR42","doi-asserted-by":"publisher","first-page":"E4769","DOI":"10.1073\/pnas.1406162111","volume":"111","author":"CF Sephton","year":"2014","unstructured":"Sephton CF et al (2014) Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc Natl Acad Sci U S A 111(44):E4769\u2013E4778","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1671_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/srep00603","volume":"2","author":"B Rogelj","year":"2012","unstructured":"Rogelj B et al (2012) Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci Rep 2:603","journal-title":"Sci Rep"},{"key":"1671_CR44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/srep00529","volume":"2","author":"S Ishigaki","year":"2012","unstructured":"Ishigaki S et al (2012) Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci Rep 2:529","journal-title":"Sci Rep"},{"issue":"12","key":"1671_CR45","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/nsmb.2163","volume":"18","author":"JI Hoell","year":"2011","unstructured":"Hoell JI et al (2011) RNA targets of wild-type and mutant FET family proteins. Nat Struct Mol Biol 18(12):1428\u20131431","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"1671_CR46","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/nn.3230","volume":"15","author":"C Lagier-Tourenne","year":"2012","unstructured":"Lagier-Tourenne C et al (2012) Divergent roles of ALS-linked proteins FUS\/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci 15(11):1488\u20131497","journal-title":"Nat Neurosci"},{"issue":"34","key":"1671_CR47","doi-asserted-by":"publisher","first-page":"24731","DOI":"10.1074\/jbc.M113.497974","volume":"288","author":"AS Mastrocola","year":"2013","unstructured":"Mastrocola AS et al (2013) The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J Biol Chem 288(34):24731\u201324741","journal-title":"J Biol Chem"},{"issue":"24","key":"1671_CR48","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1101\/gad.204602.112","volume":"26","author":"JC Schwartz","year":"2012","unstructured":"Schwartz JC et al (2012) FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev 26(24):2690\u20132695","journal-title":"Genes Dev"},{"key":"1671_CR49","doi-asserted-by":"publisher","first-page":"12143","DOI":"10.1038\/ncomms12143","volume":"7","author":"K Kapeli","year":"2016","unstructured":"Kapeli K et al (2016) Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat Commun 7:12143","journal-title":"Nat Commun"},{"issue":"Pt 24","key":"1671_CR50","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1242\/jcs.02692","volume":"118","author":"R Fujii","year":"2005","unstructured":"Fujii R, Takumi T (2005) TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J Cell Sci 118(Pt 24):5755\u20135765","journal-title":"J Cell Sci"},{"issue":"51","key":"1671_CR51","doi-asserted-by":"publisher","first-page":"E11904","DOI":"10.1073\/pnas.1810413115","volume":"115","author":"M Kamelgarn","year":"2018","unstructured":"Kamelgarn M et al (2018) ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc Natl Acad Sci U S A 115(51):E11904\u2013E11913","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1671_CR52","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1038\/ncomms8098","volume":"6","author":"T Udagawa","year":"2015","unstructured":"Udagawa T et al (2015) FUS regulates AMPA receptor function and FTLD\/ALS-associated behaviour via GluA1 mRNA stabilization. Nat Commun 6:7098","journal-title":"Nat Commun"},{"issue":"24","key":"1671_CR53","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1038\/emboj.2012.319","volume":"31","author":"M Morlando","year":"2012","unstructured":"Morlando M et al (2012) FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J 31(24):4502\u20134510","journal-title":"EMBO J"},{"issue":"52","key":"1671_CR54","doi-asserted-by":"publisher","first-page":"18459","DOI":"10.1074\/jbc.RA120.013801","volume":"295","author":"M Sevigny","year":"2020","unstructured":"Sevigny M et al (2020) FUS contributes to mTOR-dependent inhibition of translation. J Biol Chem 295(52):18459\u201318473","journal-title":"J Biol Chem"},{"issue":"13","key":"1671_CR55","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1093\/hmg\/ddt117","volume":"22","author":"C Vance","year":"2013","unstructured":"Vance C et al (2013) ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum Mol Genet 22(13):2676\u20132688","journal-title":"Hum Mol Genet"},{"issue":"16","key":"1671_CR56","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1038\/emboj.2010.143","volume":"29","author":"D Dormann","year":"2010","unstructured":"Dormann D et al (2010) ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29(16):2841\u20132857","journal-title":"EMBO J"},{"issue":"19","key":"1671_CR57","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1007\/s00018-015-1943-x","volume":"72","author":"CF Sephton","year":"2015","unstructured":"Sephton CF, Yu G (2015) The function of RNA-binding proteins at the synapse: implications for neurodegeneration. Cell Mol Life Sci 72(19):3621\u20133635","journal-title":"Cell Mol Life Sci"},{"key":"1671_CR58","doi-asserted-by":"crossref","unstructured":"Alhindi A, Boehm I, Chaytow H (2021) Small junction, big problems: neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS). J Anat","DOI":"10.1111\/joa.13463"},{"key":"1671_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2016.03.036","volume":"1647","author":"Y Shang","year":"2016","unstructured":"Shang Y, Huang EJ (2016) Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res 1647:65\u201378","journal-title":"Brain Res"},{"key":"1671_CR60","doi-asserted-by":"publisher","first-page":"826719","DOI":"10.3389\/fmolb.2022.826719","volume":"9","author":"JL Carey","year":"2022","unstructured":"Carey JL, Guo L (2022) Liquid-liquid phase separation of TDP-43 and FUS in physiology and pathology of neurodegenerative diseases. Front Mol Biosci 9:826719","journal-title":"Front Mol Biosci"},{"issue":"3","key":"1671_CR61","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1172\/JCI72723","volume":"124","author":"H Qiu","year":"2014","unstructured":"Qiu H et al (2014) ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest 124(3):981\u2013999","journal-title":"J Clin Invest"},{"issue":"21","key":"1671_CR62","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1093\/hmg\/ddx301","volume":"26","author":"M Tibshirani","year":"2017","unstructured":"Tibshirani M et al (2017) Dysregulation of chromatin remodelling complexes in amyotrophic lateral sclerosis. Hum Mol Genet 26(21):4142\u20134152","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1671_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40478-020-01111-4","volume":"9","author":"WY Ho","year":"2021","unstructured":"Ho WY et al (2021) Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits. Acta Neuropathol Commun 9(1):9","journal-title":"Acta Neuropathol Commun"},{"key":"1671_CR64","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ebiom.2017.09.005","volume":"24","author":"G Shiihashi","year":"2017","unstructured":"Shiihashi G et al (2017) Dendritic homeostasis disruption in a novel frontotemporal dementia mouse model expressing cytoplasmic fused in sarcoma. EBioMedicine 24:102\u2013115","journal-title":"EBioMedicine"},{"issue":"1","key":"1671_CR65","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41467-017-02299-1","volume":"9","author":"M Naumann","year":"2018","unstructured":"Naumann M et al (2018) Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun 9(1):335","journal-title":"Nat Commun"},{"issue":"33","key":"1671_CR66","doi-asserted-by":"publisher","first-page":"13546","DOI":"10.1073\/pnas.1107553108","volume":"108","author":"CA Wurm","year":"2011","unstructured":"Wurm CA et al (2011) Nanoscale distribution of mitochondrial import receptor Tom20 is adjusted to cellular conditions and exhibits an inner-cellular gradient. Proc Natl Acad Sci U S A 108(33):13546\u201313551","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1671_CR67","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41418-018-0060-4","volume":"25","author":"H Chen","year":"2018","unstructured":"Chen H et al (2018) Exploring the genetics and non-cell autonomous mechanisms underlying ALS\/FTLD. Cell Death Differ 25(4):648\u2013662","journal-title":"Cell Death Differ"},{"issue":"6","key":"1671_CR68","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.200908164","volume":"187","author":"H Ilieva","year":"2009","unstructured":"Ilieva H, Polymenidou M, Cleveland DW (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187(6):761\u2013772","journal-title":"J Cell Biol"},{"issue":"1","key":"1671_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-00420-5","volume":"16","author":"S Kumar","year":"2021","unstructured":"Kumar S et al (2021) Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS\/FTD. Mol Neurodegener 16(1):1","journal-title":"Mol Neurodegener"},{"issue":"12","key":"1671_CR70","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1084\/jem.20111313","volume":"208","author":"V Swarup","year":"2011","unstructured":"Swarup V et al (2011) Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J Exp Med 208(12):2429\u20132447","journal-title":"J Exp Med"},{"issue":"1","key":"1671_CR71","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s13311-014-0311-0","volume":"12","author":"P Patel","year":"2015","unstructured":"Patel P, Julien JP, Kriz J (2015) Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics 12(1):217\u2013233","journal-title":"Neurotherapeutics"},{"issue":"7","key":"1671_CR72","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1101\/gad.862101","volume":"15","author":"Y Zhu","year":"2001","unstructured":"Zhu Y et al (2001) Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 15(7):859\u2013876","journal-title":"Genes Dev"},{"issue":"12","key":"1671_CR73","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/nprot.2013.155","volume":"8","author":"M Leger","year":"2013","unstructured":"Leger M et al (2013) Object recognition test in mice. Nat Protoc 8(12):2531\u20132537","journal-title":"Nat Protoc"},{"issue":"2","key":"1671_CR74","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s13311-016-0499-2","volume":"14","author":"K Dutta","year":"2017","unstructured":"Dutta K et al (2017) Withania somnifera reverses transactive response DNA binding protein 43 proteinopathy in a mouse model of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration. Neurotherapeutics 14(2):447\u2013462","journal-title":"Neurotherapeutics"},{"issue":"2","key":"1671_CR75","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s13311-021-01015-8","volume":"18","author":"SS Thammisetty","year":"2021","unstructured":"Thammisetty SS et al (2021) Targeting TDP-43 pathology alleviates cognitive and motor deficits caused by chronic cerebral hypoperfusion. Neurotherapeutics 18(2):1095\u20131112","journal-title":"Neurotherapeutics"},{"issue":"12","key":"1671_CR76","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2013.221","volume":"9","author":"H Braak","year":"2013","unstructured":"Braak H et al (2013) Amyotrophic lateral sclerosis\u2013a model of corticofugal axonal spread. Nat Rev Neurol 9(12):708\u2013714","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1671_CR77","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","volume":"74","author":"J Brettschneider","year":"2013","unstructured":"Brettschneider J et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74(1):20\u201338","journal-title":"Ann Neurol"},{"issue":"3","key":"1671_CR78","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","volume":"43","author":"M Dadon-Nachum","year":"2011","unstructured":"Dadon-Nachum M, Melamed E, Offen D (2011) The \u201cdying-back\u201d phenomenon of motor neurons in ALS. J Mol Neurosci 43(3):470\u2013477","journal-title":"J Mol Neurosci"},{"key":"1671_CR79","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-3-319-60189-2_8","volume":"18","author":"RB Tjalkens","year":"2017","unstructured":"Tjalkens RB, Popichak KA, Kirkley KA (2017) Inflammatory Activation of Microglia and Astrocytes in Manganese Neurotoxicity. Adv Neurobiol 18:159\u2013181","journal-title":"Adv Neurobiol"},{"issue":"2","key":"1671_CR80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.expneurol.2010.11.019","volume":"227","author":"WW Yang","year":"2011","unstructured":"Yang WW et al (2011) Relationship between neuropathology and disease progression in the SOD1(G93A) ALS mouse. Exp Neurol 227(2):287\u2013295","journal-title":"Exp Neurol"},{"issue":"1","key":"1671_CR81","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12974-019-1589-y","volume":"16","author":"JH Jara","year":"2019","unstructured":"Jara JH et al (2019) MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology. J Neuroinflamm 16(1):196","journal-title":"J Neuroinflamm"},{"issue":"6","key":"1671_CR82","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1(6):a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"1671_CR83","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1212\/WNL.57.7.1282","volume":"57","author":"ME Alexianu","year":"2001","unstructured":"Alexianu ME, Kozovska M, Appel SH (2001) Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57(7):1282\u20131289","journal-title":"Neurology"},{"issue":"3","key":"1671_CR84","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#","volume":"23","author":"ED Hall","year":"1998","unstructured":"Hall ED, Oostveen JA, Gurney ME (1998) Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23(3):249\u2013256","journal-title":"Glia"},{"issue":"9","key":"1671_CR85","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/jnen\/63.9.964","volume":"63","author":"W Zhao","year":"2004","unstructured":"Zhao W et al (2004) Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol 63(9):964\u2013977","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1671_CR86","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yexcr.2014.09.034","volume":"331","author":"SS Jackson","year":"2015","unstructured":"Jackson SS et al (2015) Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-kappaB signaling. Exp Cell Res 331(1):58\u201372","journal-title":"Exp Cell Res"},{"key":"1671_CR87","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1186\/1471-2164-11-S4-S25","volume":"11","author":"A Grover","year":"2010","unstructured":"Grover A et al (2010) Inhibition of the NEMO\/IKKbeta association complex formation, a novel mechanism associated with the NF-kappaB activation suppression by Withania somnifera\u2019s key metabolite withaferin A. BMC Genom 11:S25","journal-title":"BMC Genom"},{"issue":"48","key":"1671_CR88","doi-asserted-by":"publisher","first-page":"33161","DOI":"10.1074\/jbc.M114.582478","volume":"289","author":"C Hooper","year":"2014","unstructured":"Hooper C et al (2014) Covalent modification of the NF-kappaB essential modulator (NEMO) by a chemical compound can regulate its ubiquitin binding properties in vitro. J Biol Chem 289(48):33161\u201333174","journal-title":"J Biol Chem"},{"key":"1671_CR89","doi-asserted-by":"crossref","unstructured":"Pozzi S et al (2020) Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons. JCI Insight 5(21)","DOI":"10.1172\/jci.insight.140420"},{"issue":"1","key":"1671_CR90","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/nen.0b013e31802c396b","volume":"66","author":"S Sasaki","year":"2007","unstructured":"Sasaki S, Iwata M (2007) Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 66(1):10\u201316","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1671_CR91","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/BF00308929","volume":"80","author":"K Okamoto","year":"1990","unstructured":"Okamoto K et al (1990) Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosis. Acta Neuropathol 80(2):222\u2013226","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1671_CR92","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1523\/JNEUROSCI.1233-11.2012","volume":"32","author":"J Magrane","year":"2012","unstructured":"Magrane J et al (2012) Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J Neurosci 32(1):229\u2013242","journal-title":"J Neurosci"},{"issue":"2","key":"1671_CR93","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrn3156","volume":"13","author":"ZH Sheng","year":"2012","unstructured":"Sheng ZH, Cai Q (2012) Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 13(2):77\u201393","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"1671_CR94","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/ene.15243","volume":"29","author":"A Maranzano","year":"2022","unstructured":"Maranzano A et al (2022) Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis. Eur J Neurol 29(5):1402\u20131409","journal-title":"Eur J Neurol"},{"issue":"9","key":"1671_CR95","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1007\/s10072-022-06157-x","volume":"43","author":"EN Aiello","year":"2022","unstructured":"Aiello EN et al (2022) Cognition and motor phenotypes in ALS: a retrospective study. Neurol Sci 43(9):5397\u20135402","journal-title":"Neurol Sci"},{"issue":"2","key":"1671_CR96","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","volume":"35","author":"NT Olney","year":"2017","unstructured":"Olney NT, Spina S, Miller BL (2017) Frontotemporal dementia. Neurol Clin 35(2):339\u2013374","journal-title":"Neurol Clin"},{"key":"1671_CR97","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-12-804766-8.00015-7","volume":"167","author":"EM Devenney","year":"2019","unstructured":"Devenney EM, Ahmed RM, Hodges JR (2019) Frontotemporal dementia. Handb Clin Neurol 167:279\u2013299","journal-title":"Handb Clin Neurol"},{"key":"1671_CR98","doi-asserted-by":"crossref","unstructured":"Qiu H et al (2021) ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest 131(7)","DOI":"10.1172\/JCI149564"},{"issue":"6","key":"1671_CR99","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cub.2005.01.058","volume":"15","author":"R Fujii","year":"2005","unstructured":"Fujii R et al (2005) The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol 15(6):587\u2013593","journal-title":"Curr Biol"},{"issue":"1","key":"1671_CR100","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1038\/s41467-021-23188-8","volume":"12","author":"S Sahadevan","year":"2021","unstructured":"Sahadevan S et al (2021) Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS. Nat Commun 12(1):3027","journal-title":"Nat Commun"},{"issue":"5","key":"1671_CR101","doi-asserted-by":"publisher","first-page":"109080","DOI":"10.1016\/j.celrep.2021.109080","volume":"35","author":"UB Eyo","year":"2021","unstructured":"Eyo UB et al (2021) Microglia provide structural resolution to injured dendrites after severe seizures. Cell Rep 35(5):109080","journal-title":"Cell Rep"},{"key":"1671_CR102","doi-asserted-by":"publisher","first-page":"e04047","DOI":"10.7554\/eLife.04047","volume":"3","author":"WC Risher","year":"2014","unstructured":"Risher WC et al (2014) Astrocytes refine cortical connectivity at dendritic spines. Elife 3:e04047","journal-title":"Elife"},{"key":"1671_CR103","doi-asserted-by":"publisher","first-page":"21096","DOI":"10.1038\/srep21096","volume":"6","author":"YB Zhu","year":"2016","unstructured":"Zhu YB et al (2016) Astrocyte-derived phosphatidic acid promotes dendritic branching. Sci Rep 6:21096","journal-title":"Sci Rep"},{"issue":"5","key":"1671_CR104","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/glia.23298","volume":"66","author":"A Kia","year":"2018","unstructured":"Kia A et al (2018) Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia 66(5):1016\u20131033","journal-title":"Glia"},{"issue":"3","key":"1671_CR105","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.stemcr.2022.01.004","volume":"17","author":"SY Kerk","year":"2022","unstructured":"Kerk SY et al (2022) Homozygous ALS-linked FUS P525L mutations cell- autonomously perturb transcriptome profile and chemoreceptor signaling in human iPSC microglia. Stem Cell Rep 17(3):678\u2013692","journal-title":"Stem Cell Rep"},{"issue":"9","key":"1671_CR106","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3390\/antiox9090901","volume":"9","author":"E Obrador","year":"2020","unstructured":"Obrador E et al (2020) Oxidative stress, neuroinflammation and mitochondria in the pathophysiology of amyotrophic lateral sclerosis. Antioxidants (Basel) 9(9):901","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"1671_CR107","doi-asserted-by":"publisher","first-page":"e001920","DOI":"10.1161\/JAHA.115.001920","volume":"4","author":"A Meissner","year":"2015","unstructured":"Meissner A et al (2015) Tumor necrosis factor-alpha underlies loss of cortical dendritic spine density in a mouse model of congestive heart failure. J Am Heart Assoc 4(5):e001920","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1671_CR108","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-015-1527-8","volume":"131","author":"C Zou","year":"2016","unstructured":"Zou C et al (2016) Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer\u2019s disease. Acta Neuropathol 131(2):235\u2013246","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1671_CR109","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1523\/JNEUROSCI.2235-16.2016","volume":"37","author":"Y Liu","year":"2017","unstructured":"Liu Y et al (2017) TNF-alpha differentially regulates synaptic plasticity in the hippocampus and spinal cord by microglia-dependent mechanisms after peripheral nerve injury. J Neurosci 37(4):871\u2013881","journal-title":"J Neurosci"},{"issue":"4","key":"1671_CR110","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/jnc.13008","volume":"132","author":"DN Doll","year":"2015","unstructured":"Doll DN et al (2015) Rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity. J Neurochem 132(4):443\u2013451","journal-title":"J Neurochem"},{"key":"1671_CR111","doi-asserted-by":"publisher","first-page":"132931","DOI":"10.1016\/j.neulet.2017.06.050","volume":"710","author":"J van Horssen","year":"2019","unstructured":"van Horssen J, van Schaik P, Witte M (2019) Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders? Neurosci Lett 710:132931","journal-title":"Neurosci Lett"},{"key":"1671_CR112","doi-asserted-by":"publisher","first-page":"103396","DOI":"10.1016\/j.mcn.2019.103396","volume":"100","author":"J Gao","year":"2019","unstructured":"Gao J et al (2019) TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol Cell Neurosci 100:103396","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"1671_CR113","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.celrep.2016.09.004","volume":"17","author":"G Lopez-Domenech","year":"2016","unstructured":"Lopez-Domenech G et al (2016) Loss of dendritic complexity precedes neurodegeneration in a mouse model with disrupted mitochondrial distribution in mature dendrites. Cell Rep 17(2):317\u2013327","journal-title":"Cell Rep"},{"issue":"11\u201312","key":"1671_CR114","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1101\/gad.335836.119","volume":"34","author":"YL Tsai","year":"2020","unstructured":"Tsai YL et al (2020) ALS\/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs. Genes Dev 34(11\u201312):785\u2013805","journal-title":"Genes Dev"},{"issue":"1","key":"1671_CR115","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1038\/s41598-018-33964-0","volume":"8","author":"T Nakaya","year":"2018","unstructured":"Nakaya T, Maragkakis M (2018) Amyotrophic lateral sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity. Sci Rep 8(1):15575","journal-title":"Sci Rep"},{"issue":"1","key":"1671_CR116","doi-asserted-by":"publisher","first-page":"13613","DOI":"10.1038\/s41598-021-93189-6","volume":"11","author":"S Salam","year":"2021","unstructured":"Salam S et al (2021) Identification of a novel interaction of FUS and syntaphilin may explain synaptic and mitochondrial abnormalities caused by ALS mutations. Sci Rep 11(1):13613","journal-title":"Sci Rep"},{"issue":"1","key":"1671_CR117","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/hmg\/ddr448","volume":"21","author":"ML Tradewell","year":"2012","unstructured":"Tradewell ML et al (2012) Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS\/TLS harbouring ALS-linked mutations. Hum Mol Genet 21(1):136\u2013149","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1671_CR118","doi-asserted-by":"publisher","first-page":"e1005357","DOI":"10.1371\/journal.pgen.1005357","volume":"11","author":"J Deng","year":"2015","unstructured":"Deng J et al (2015) FUS interacts with HSP60 to promote mitochondrial damage. PLoS Genet 11(9):e1005357","journal-title":"PLoS Genet"},{"issue":"16","key":"1671_CR119","doi-asserted-by":"publisher","first-page":"13395","DOI":"10.1074\/jbc.M011176200","volume":"276","author":"H Uranishi","year":"2001","unstructured":"Uranishi H et al (2001) Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J Biol Chem 276(16):13395\u201313401","journal-title":"J Biol Chem"},{"issue":"13","key":"1671_CR120","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1016\/j.celrep.2019.11.094","volume":"29","author":"TA Shelkovnikova","year":"2019","unstructured":"Shelkovnikova TA et al (2019) Antiviral immune response as a trigger of FUS proteinopathy in amyotrophic lateral sclerosis. Cell Rep 29(13):4496\u20134508","journal-title":"Cell Rep"},{"issue":"1","key":"1671_CR121","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1038\/s41598-019-41040-4","volume":"9","author":"MA Ajmone-Cat","year":"2019","unstructured":"Ajmone-Cat MA et al (2019) Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci Rep 9(1):4572","journal-title":"Sci Rep"},{"issue":"4","key":"1671_CR122","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.it.2011.01.005","volume":"32","author":"DV Krysko","year":"2011","unstructured":"Krysko DV et al (2011) Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 32(4):157\u2013164","journal-title":"Trends Immunol"},{"issue":"10","key":"1671_CR123","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","volume":"43","author":"MM Lin","year":"2022","unstructured":"Lin MM et al (2022) Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol Sin 43(10):2439\u20132447","journal-title":"Acta Pharmacol Sin"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01671-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01671-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01671-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T21:42:14Z","timestamp":1700170934000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01671-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01671-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"assertion":[{"value":"4 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}